News Bulletin
Monday, June 15, 2026
Evening Edition
Economic Numbers:
|
Time |
Event |
Actual |
Forecast |
Previous |
|
8:30 |
5.7 |
13.2 |
19.6 |
|
|
9:15 |
0.0167 |
|
0.0137 |
|
|
9:15 |
0.001 |
0.003 |
0.009 |
|
|
9:15 |
0 |
|
0.007 |
|
|
9:15 |
0.762 |
0.762 |
0.761 |
|
|
10:00 |
35 |
36 |
37 |
|
|
11:30 |
0.0364 |
|
0.0364 |
|
|
11:30 |
0.0368 |
|
0.0369 |
Indices
|
|
CLOSE |
50 DMA |
200 DMA |
|
DJIA |
51,671.03 |
49,663.48 |
48,060.75 |
|
NASDAQ |
26,683.94 |
25,306.28 |
23,456.09 |
|
S&P 500 |
7,554.29 |
7,267.24 |
6,887.77 |
Earnings Calendar:
(EPS: Earning Per Share / Rev: Revenue / Mkt Cap : market Capital/ BMO :
Before Market Opening /AMC : After Market Close)
|
COMPANY |
EPS |
Consensus |
Previous |
Revenue |
Consensus |
Previous |
MarketCap |
Fiscal |
Time |
|
0.85 |
590.16M |
$1.62B |
Q4 |
PM |
Market
News:
Here are some of the biggest premarket US stock movers today:
Neurocrine Biosciences, Inc. (Nasdaq:
NBIX) today announced clinical findings from the first
retrospective case series in pediatric and adult
patients with classic congenital adrenal hyperplasia (CAH) due to
11β‑hydroxylase deficiency. This subtype was not previously studied
in clinical trials of CRENESSITY® (crinecerfont) and
is the second most common form of classic CAH after 21-hydroxylase deficiency,
accounting for approximately 5% of cases. The findings were presented at the
Endocrine Society’s annual meeting, ENDO 2026, in Chicago.
TON
Strategy Company (“TON Strategy” or the “Company”) (Nasdaq:
TONX), a digital asset treasury company dedicated to
supporting the TON ecosystem, today highlighted the TON community’s rebrand of Toncoin, the native currency of The Open Network, to
“Gram.”
The Ensign
Group, Inc. (Nasdaq: ENSG)
(“Ensign” or the “Company”), the parent company of the EnsignTM
group of companies, which invest in and provide skilled nursing and senior
living services, physical, occupational and speech therapies, other
rehabilitative and healthcare services, and real estate, announced today that
its Board of Directors has approved a $60 million increase to the Company’s
previously approved $40 million stock repurchase program, bringing the
Company’s total authorized repurchase capacity to $100 million. Repurchases
under the expanded program are expected to commence in the near term.
J-Star
Holding Co., Ltd. (Nasdaq: YMAT)
(“J-Star” or the “Company”), today announced that on June 12, 2026, it received
a Staff Delisting Determination Letter from the staff of The Nasdaq Stock Market LLC (“Nasdaq”)
indicating that the Company is not in compliance with Nasdaq
Listing Rule 5550(a)(2), which requires listed
companies to maintain a minimum bid price of $1.00 per share.
Rhythm
Pharmaceuticals, Inc. (Nasdaq: RYTM),
a global commercial-stage biopharmaceutical company focused on transforming the
lives of patients living with rare neuroendocrine
diseases, today announced new data from multiple presentations during the Endocrine
Society’s Annual Meeting (ENDO 2026) in Chicago.
Victoria’s
Secret & Co. (NYSE:VSCO) to positive from stable on Monday and
affirmed its ’BB-’ issuer credit rating. The ratings
agency cited better-than-expected operating performance and double-digit market
share growth during the first quarter of 2026.
Lockheed
Martin (NYSE:LMT) announced today that the U.S. Space
Force awarded the company a $514 million contract to build Global Positioning
System IIIF Space Vehicles 23 and 24. The contract brings Lockheed Martin’s
total GPS IIIF commitment to 14 spacecraft.
For internal use only